Varicella complications requiring hospitalization in four hospitals in Santiago, Chile: Clinical spectrum and estimation of direct costs;Complicaciones en ninos con varicela en cuatro hospitales de Santiago- Chile: Espectro clínico y estimación de costos directos

Revista Medica de Chile

Volumn 129, Issue 4, 2001, Pages 397-404

  Abarca V, Katia ^a   Hirsch B, Tamara ^b   Potin S, Marcela ^b   Perret P, Cecilia ^b   Zamorano R, Juana ^b   González C, Cecilia ^b   Vial C, Pablo ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b NONE

Author keywords

Bacterial infections; Chicken pox; Cost of illness; Viral vaccines

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHICKENPOX; CHILD; CHILE; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; BACTERIAL INFECTIONS; CHICKENPOX; CHILD; CHILD, PRESCHOOL; CHILE; DIRECT SERVICE COSTS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES;

EID: 0035316442     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. GUESS HA, BROUGHTON DD, MELTON LJ AND KURLAND LT. Population-based studies of varicella complications. Pediatrics 1986; 78(suppl): 723-7.
2. CHOO PW, DONAHUE JG, MANSON JA AND PLATT R. The epidemiology of varicella and its complications. J Infect Dis 1995; 172: 706-12.
3. FELDMAN S. Varicella zoster virus. In: Christian C. Patrick. Infections in Immunocompromised Infants and Children. Ed. Churchill Livingstone Inc. 1992, 641-54.
4. CENTERS FOR DISEASE CONTROL AND PREVENTION. Varicella-related deaths among adults. United States MMWR Morb Mortal Wkly Rep 1997; 46: 409-12
5. BOVILL B AND BANNISTER B. Review of 26 years' Hospital Admissions for Chickenpox in North London. J Infect 1998; 36 (Suppl) 1: 17-23.
6. WHITLEY RJ. Varicella Zoster virus. In: Mandell, Douglas and Benett. Principles and Practice of Infectious Diseases. 4th Ed. New York Churchill Livingstone Inc 1995: 1345-50.
7. JAEGGI A, ZURBRUEGG RP AND AEBI C. Complications of varicella in a defined central European population. Arch Dis Child 1998; 79: 472-7
8. AEBI C, AHMED A AND RAMILO O. Bacterial complications of primary varicella in children. Clin Infect Dis 1996; 23: 698-705
9. JACKSON MA, BURRY VF AND OLSON LLC. Complications of varicella requiring hospitalisation in previously healthy children. Pediatr Infect Dis J 1992; 11: 441-5.
10. FISCHBACHER CM AND GREEN ST. Varicella and Life-threating Streptococcal Infection. Scand J Infect Dis 1987; 19: 519-20
11. BROGAN TV, NIZET V, WALDHAUSEN JH, RUBENS GE, CLARKE WR. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995; 14: 588-94
12. DOCTOR A, HARPER MG AND FLEISHER GR. Group A ß-Hemolytic Streptococcal bacteremia: Historical Overview, Changing Incidences and Recent Association to Varicella. Pediatrics 1995; 96: 428-33.
13. SCHRECK P, SCHRECK P, BRADLEY J AND CHAMBERS H. Musculoeskeletal Complicactions of Varicella. J Bone Joint Surgery 1996; 78-A: 1713-9.
14. BURKE GA AND CHAMBERS TL. Musculoeskeletal side-effects of varicella. Lancet 1997; 349: 818-9.
15. FLEISHER G, HENRY W, MCSORLEY M, ARBETER A, PLOTKIN S. Life threatening complications of varicella. Am J Dis Child 1981; 135: 896-9
16. PETERSON CL, VUGIA DJ, MEYERS HB, CHAO SM, VOGT JT, LANSON J, BRUNELL P, ET AL. Risk factors for invasive group A streptococcal infections in children with varicella: a case-control study. Pediatr Infect Dis J 1996; 15: 151-6.
17. PREBLUD SR, BREGMAN DJ AND VERNON LL. Deaths from varicella in infants. Pediatr Infect Dis 1985; 4: 503-7.
18. LAGOS R, POTIN M AND TANAKA J. Seroprevalencia de anticuerpos antivaricela zoster en población sana del área Norte de Santiago, 1996. Panamerican Ped Congress (Abstract). Santiago Chile; April 1998
19. Anuarios de Notificación Obligatoria. Ministerio de Salud, Chile 1996.
20. Instituto Nacional de Estadisticas 1998.
21. PREBLUD SR. Age-specific risks of varicella complications. Pediatrics 1981; 68:14-7.
22. FORNARO P, GANDINI F, MARIN M, PEDRAZZI CH, PICCOLI P, TOGMETTI MD, ASSAEL BM. ET AL. Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Pediatr Infect Dis J 1999; 18: 414-9.
23. ABARCA K, PERRET C, DABANCH J, MAGGI L AND HEITMANN I. Infecciones invasivas por Streptococcus ßhemolítico Grupo A en Santiago. Libro de resúmenes XVI Congreso Chileno de Infectología, Agosto 1999.
24. ZERR DM, ALEXANDER ER, DUCHIN JS, KOUTSKY LA, RUBENS CE. A Case-Control Study of Necrotizing Fasciitis During Primary Varicella. Pediatrics 1999; 103: 783-90.
25. ROSS AH. Modification of chicken pox in family contacts by administration of gamma globulin. N Engl J Med 1962; 267: 369-76.
26. RIMAILHO R, RIOU D, RICHARD C AND AUZEPY P. Fulminant necrotizing Fasciitis and Nonsteroidal Anti-Inflamatory Drugs. The Journal of Infectious Diseases 1987; 1: 143-6.
27. PATEL H, MAC AHTHUR C AND JOHNSON D. Recent Corticoid Use and the Risk of Complicated Varicella in Otherwise Immunocompetent Children. Arch Pediatr Adolesc Med 1996; 150: 409-14.
28. LAW B, FITZSIMOS C, FORD-JONES L, MAC DONALD N, DERY P, VAUDRY W, MILLS E; ET AL. Cost of Chickenpox in Canada: Part I. Cost of Uncomplicated Cases. Pediatrics 1999; 104: 1-6.
29. LAW B, FITZSIMOS C, FORD-JONES L, MCCORMICK J, DIVIÈRE M, AND MEMBERS OF THE IMMUNIZATION MONITORING PROGRAM ACTIVE (IMPACT). Cost of Chickenpox in Canada: Part II. Cost of Complicated Cases and Total Economic Impact. Pediatrics 1999; 104: 7-14.
30. HUSE DM, MEISSNER HC, LACEY MJ AND OSTER G. Childhood vaccination against chickenpox: an analysis of benefits and costs. J Pediatr 1994; 124: 869-74.
31. PAUL JE, MAUSKOPF JA AND BELL L. Cost-Consequence Models for Varicella-Zoster Virus Infections. Pharmacotherapy 1995; 15 (5Pt2): 49S-58S.
32. LIEU TA, COCHI SL, BLACK SB, HALLORANE E, SHINEFIELD HR; HOLMES SJ; WHARTON M; WASHINGTON E. Cost-effectiveness of a Routine Varicella Vaccination Program for US Children. JAMA 1994; 271: 375-81.